Pain Management with Intravenous Ketorolac
- 1 March 1993
- journal article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 27 (3) , 307-308
- https://doi.org/10.1177/106002809302700310
Abstract
OBJECTIVE: To report a case in which intravenous ketorolac was used successfully on a chronic basis to treat cancer pain. DATA SOURCES: Clinical and compatibility studies obtained through a computer literature search. STUDY SELECTION: We identified five reports that specifically addressed intravenous dosing of ketorolac. DATA SYNTHESIS: A 41-year-old man received pain relief from intravenous injections of ketorolac for 11 months. As far as we know, there are no other reports in the literature in which intravenous ketorolac has been used on a chronic basis. CONCLUSIONS: Experience at our institution indicates that intravenous ketorolac is a useful, well-tolerated nonsteroidal antiinflammatory drug that should be investigated further for use in selected pain models.Keywords
This publication has 7 references indexed in Scilit:
- POSTOPERATIVE HEMATOMAS ASSOCIATED WITH TORADOLPlastic and Reconstructive Surgery, 1991
- Comparison of Intravenous Ketorolac Tromethamine and Morphine Sulfate in the Treatment of Postoperative PainPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1990
- Effects of ketorolac tromethamine on hemostasis in volunteersClinical Pharmacology & Therapeutics, 1988
- Ketorolac tromethamine as compared with morphine sulfate for treatment of postoperative painClinical Pharmacology & Therapeutics, 1987
- Comparison of Intramuscular Ketorolac Tromethamine and Morphine Sulfate for Analgesia of Pain After Major SurgeryPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1986
- Renal Syndromes Associated with Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1984